Cardax Pharma, Inc. — Form D
Cardax Pharma, Inc. of HONOLULU, HI, a company, filed a Form D exempt-offering notice with the SEC on 2014-01-17. The offering totals $5.0M, of which $2.1M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2014-01-17
- Form: D
- Accession: 0001579166-14-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $2.1M
- Remaining: $2.9M
- Minimum investment: $12K
- Investors: 26
- Date of first sale: 2014-01-03
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-210330
Issuer
- Name: Cardax Pharma, Inc.
- CIK: 0001579166
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 2800 WOODLAWN DRIVE, HONOLULU, HI, 96822
- Phone: 808-457-1399
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Frank C Herringer | Director | Thousand Oaks, CA |
| Nicholas G Mitsakos | Director | Honolulu, HI |
| David G Watumull | Executive Officer | Honolulu, HI |
Other filings by this issuer (1)
More